The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight - ATTAIN-OSA - Eli Lilly and CompanySee more
Lupus
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - POETYK SLE-2 - Bristol-Myers SquibbSee more
Renal disease
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
Sleep disorders
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight - ATTAIN-OSA - Eli Lilly and CompanySee more
